12 2 STA T .4 1 9 9 PUBLIC LA W 11 0–3 92 —O CT. 13 , 200 8Dev e lopm e nt, t h e Ag en cyf o rH e a lthcare R e s earch an dQu al i ty, the Health Resources and S ervices Administration, the U nited States -M e x ico B order Health C ommission, and other F ederal departments and agencies that carry out significant activities related to tu b erculosis
- ‘
‘ ( B ) State and local tuberculosis control and public health officials; ‘‘(C) individuals w ho are scientists, physicians, laboratorians, and other health professionals who represent disciplines relevant to tuberculosis elimination; and ‘‘(D) members of national and international nongovern- mental organi z ations established to address the elimination of tuberculosis .’ ’. (b) R ULEOF CO NSTR U C T I ON RE GA R D ING CURRENT ME MB ER- S H I P . —W ith respect to the advisory council under section 317E (f) of the P ublic Health Service Act, the amendments made by sub- section (a) may not be construed as terminating the membership on such council of any individual serving as such a member as of the day before the date of the enactment of this Act. (c) FEDERAL T UBERCULOSIS TAS K FORCE.—Section 317E of the Public Health Service Act ( 42 U.S.C. 247b –6 ) is amended— (1) by redesignating subsection (g) as subsection (h); and (2) by inserting after subsection (f) the following subsection
‘‘(g) FEDERAL TUBERCULOSIS TASK FORCE.— ‘‘(1) DUTIES.—The Federal Tuberculosis Tas k Force (in this subsection referred to as the ‘Task Force’) shall provide to the Secretary and other appropriate Federal officials advice on research into new tools under subsection (b)(2), including advice regarding the efficient utilization of the Federal resources involved. ‘‘(2) COMPREHENSI V E PLAN FOR NE W TOOLS DEVELOPMENT.— I n carrying out paragraph (1), the Task Force shall make recommendations on the development of a comprehensive plan for the creation of new tools for the elimination of tuberculosis, including drugs, diagnostics, and vaccines. ‘‘(3) CONSULTATION.—In developing the comprehensive plan under paragraph (1), the Task Force shall consult with external parties including representatives from groups such as— ‘‘(A) scientists, physicians, laboratorians, and other health professionals who represent the specialties and dis- ciplines relevant to the research under consideration; ‘‘(B) members from public-private partnerships, private entities, or foundations (or both) engaged in activities rel- evant to research under consideration; ‘‘(C) members of national and international nongovern- mental organizations established to address tuberculosis elimination; ‘‘(D) members from the general public who are knowledgeable with respect to tuberculosis including individuals who have or have had tuberculosis; and ‘‘(E) scientists, physicians, laboratorians, and other health professionals who reside in a foreign country with a substantial incidence or prevalence of tuberculosis, and who represent the specialties and disciplines relevant to the research under consideration.’’. Recom me nda-ti on s.42USC 24 7b–6 note.
�
